{
    "id": "malignant_hyperthermia_priorityAction_v1",
    "type": "priorityAction",
    "stem": "A client undergoing general anesthesia with sevoflurane develops masseter muscle rigidity, sinus tachycardia at 150/min, and a rapid increase in end-tidal carbon dioxide (ETCO2) to 70 mmHg. The client's core temperature is now 105°F (40.6°C). The surgeon has stopped the procedure. Which action will the nurse anticipate and prepare for *immediately*?",
    "options": [
        {
            "id": "a",
            "text": "Apply ice packs to the client's axilla and groin."
        },
        {
            "id": "b",
            "text": "Administer IV dantrolene sodium as prescribed."
        },
        {
            "id": "c",
            "text": "Obtain an arterial blood gas (ABG) sample."
        },
        {
            "id": "d",
            "text": "Increase the flow rate of the anesthetic gas."
        }
    ],
    "correctOptionId": "b",
    "scoring": {
        "method": "dichotomous",
        "maxPoints": 1
    },
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "takeAction",
        "nclexCategory": "Physiological Adaptation",
        "difficulty": 4,
        "topicTags": [
            "Malignant Hyperthermia",
            "Perioperative Emergency",
            "Pharmacology",
            "Anesthesia Complications"
        ]
    },
    "answerBreakdown": {
        "correctOptionId": "b",
        "answerRationale": {
            "optionId": "b",
            "content": "This is the immediate, life-saving priority. Malignant hyperthermia (MH) is caused by a massive, uncontrolled efflux of calcium (Ca2+) from the sarcoplasmic reticulum in skeletal muscle, triggered by volatile anesthetics or succinylcholine. This intracellular calcium overload drives a hypermetabolic state, causing muscle rigidity, heat production, and acidosis. Dantrolene is a direct-acting muscle relaxant that specifically antagonizes the ryanodine receptor 1 (RYR1), blocking the release of calcium. By halting the calcium leak at its source, dantrolene is the only intervention that stops the underlying pathophysiologic cascade. All other actions are supportive and will fail if the primary process is not stopped."
        },
        "distractorRationale": [
            {
                "optionId": "a",
                "content": "This action is incorrect as the priority. While active cooling is a necessary component of MH management, it only treats the symptom of hyperthermia through external heat dissipation (conduction). It does not stop the source of the heat production, which is the runaway cellular metabolism caused by excessive intracellular calcium. The body's core temperature will continue to rise uncontrollably until the underlying metabolic process is halted by dantrolene. Initiating cooling before or instead of administering the antidote would allow irreversible cellular damage to occur."
            },
            {
                "optionId": "c",
                "content": "This action is incorrect as the priority. Obtaining an ABG is a critical diagnostic and monitoring step, not the primary therapeutic intervention. The ABG will confirm a severe mixed respiratory and metabolic acidosis due to hypercarbia and lactate production from the hypermetabolic state. However, the time taken to obtain and analyze the sample would critically delay the administration of dantrolene, the definitive treatment. The clinical diagnosis of MH is made based on signs like hypercarbia, rigidity, and tachycardia, and treatment must begin immediately upon suspicion."
            },
            {
                "optionId": "d",
                "content": "This action is incorrect and extremely dangerous. The volatile anesthetic gas (sevoflurane) is the triggering agent responsible for initiating the MH crisis in a susceptible individual. Increasing its concentration would accelerate the abnormal release of calcium from the sarcoplasmic reticulum, intensifying the hypermetabolic state. This would worsen muscle rigidity, accelerate CO2 and heat production, and hasten cardiovascular collapse. The first step in managing MH is to immediately discontinue all triggering agents and hyperventilate the client with 100% oxygen."
            }
        ]
    },
    "educational": {
        "questionTrap": "The primary trap in this question is selecting a supportive or diagnostic measure over the definitive antidote. Both cooling the client (A) and assessing acid-base status (C) are correct actions in the overall management of malignant hyperthermia, but they do not stop the underlying cellular process. The NGN-style question requires identifying the single action that will reverse the life-threatening pathophysiology, which is the administration of dantrolene to block calcium release.",
        "mnemonics": "Use the mnemonic **SODA** for immediate MH interventions:\n\n*   **S**top: Discontinue all triggering agents (volatile anesthetics, succinylcholine).\n*   **O**xygenate: Hyperventilate with 100% O2 to flush CO2 and correct hypoxia.\n*   **D**antrolene: Administer IV dantrolene immediately (2.5 mg/kg).\n*   **A**ddress: Treat hyperthermia (active cooling), acidosis (bicarbonate), and arrhythmias."
    }
}